Stocks Overview

LAST PRICE
42.1200
TODAY'S CHANGE (%)
Trending Down-0.1700 (-0.4020%)

Bid / Lots
39.0000/ 1
Ask / Lots
43.4200/ 1
Open / Previous Close
42.4900 / 42.2900
Day Range
Low 41.6600
High 42.8650
52 Week Range
Low 15.7600
High 49.5799
Volume
563,205
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 42.29
Time	Volume	CRNX
09:32 ET	3516	42.04
09:34 ET	511	42.165
09:36 ET	351	42.19
09:38 ET	745	42.38
09:39 ET	100	42.07
09:43 ET	1000	42.2
09:45 ET	431	42.24
09:48 ET	100	42.19
09:52 ET	200	42.25
09:54 ET	7238	42.515
09:56 ET	219	42.4
09:57 ET	300	42.74
09:59 ET	100	42.69
10:01 ET	401	42.605
10:03 ET	300	42.58
10:08 ET	400	42.68
10:10 ET	200	42.655
10:14 ET	300	42.65
10:15 ET	200	42.57
10:17 ET	200	42.465
10:19 ET	15629	42.545
10:21 ET	100	42.63
10:24 ET	307	42.47
10:26 ET	636	42.48
10:28 ET	100	42.47
10:30 ET	758	42.58
10:32 ET	100	42.72
10:33 ET	400	42.64
10:35 ET	776	42.82
10:37 ET	200	42.82
10:39 ET	1669	42.865
10:42 ET	800	42.745
10:46 ET	1238	42.49
10:48 ET	400	42.5
10:50 ET	636	42.48
10:51 ET	908	42.3517
10:53 ET	8518	42.43
10:55 ET	300	42.435
10:57 ET	22313	42.37
11:00 ET	5227	42.25
11:02 ET	303	42.335
11:04 ET	6614	42.4575
11:06 ET	4096	42.3
11:09 ET	2800	42.24
11:11 ET	800	42.11
11:13 ET	2500	42.26
11:15 ET	3600	42.3
11:18 ET	5536	42.32
11:20 ET	2200	42.57
11:22 ET	681	42.43
11:24 ET	51190	42.515
11:26 ET	5038	42.415
11:27 ET	1700	42.41
11:29 ET	700	42.39
11:31 ET	100	42.39
11:33 ET	400	42.395
11:36 ET	1700	42.25
11:38 ET	1400	42.27
11:40 ET	1400	42.25
11:42 ET	200	42.295
11:44 ET	1425	42.345
11:45 ET	1200	42.4
11:47 ET	1500	42.36
11:49 ET	400	42.365
11:51 ET	425	42.415
11:54 ET	100	42.45
11:56 ET	300	42.455
11:58 ET	800	42.49
12:00 ET	300	42.45
12:02 ET	400	42.4575
12:03 ET	300	42.455
12:05 ET	1600	42.46
12:07 ET	800	42.37
12:09 ET	800	42.48
12:12 ET	359	42.44
12:14 ET	443	42.55
12:16 ET	849	42.59
12:18 ET	520	42.58
12:20 ET	200	42.58
12:21 ET	100	42.52
12:23 ET	100	42.615
12:25 ET	100	42.6147
12:27 ET	800	42.77
12:30 ET	100	42.72
12:34 ET	1500	42.635
12:36 ET	100	42.635
12:38 ET	200	42.69
12:39 ET	1273	42.73
12:41 ET	1210	42.685
12:43 ET	300	42.67
12:48 ET	500	42.64
12:50 ET	100	42.54
12:52 ET	600	42.545
12:54 ET	900	42.56
12:56 ET	400	42.56
12:57 ET	850	42.61
01:01 ET	209	42.58
01:03 ET	200	42.645
01:06 ET	1994	42.61
01:08 ET	600	42.53
01:10 ET	200	42.565
01:12 ET	100	42.57
01:14 ET	1856	42.67
01:15 ET	1505	42.71
01:17 ET	782	42.675
01:19 ET	1000	42.6401
01:21 ET	900	42.68
01:24 ET	772	42.65
01:26 ET	300	42.62
01:28 ET	300	42.62
01:30 ET	200	42.59
01:32 ET	600	42.59
01:33 ET	5479	42.5182
01:35 ET	300	42.5
01:37 ET	443	42.5
01:39 ET	500	42.52
01:42 ET	100	42.49
01:44 ET	300	42.54
01:46 ET	200	42.54
01:48 ET	500	42.525
01:50 ET	964	42.55
01:51 ET	100	42.56
01:53 ET	100	42.58
01:55 ET	500	42.5
01:57 ET	100	42.5
02:00 ET	100	42.525
02:02 ET	400	42.52
02:04 ET	400	42.5
02:06 ET	300	42.54
02:09 ET	550	42.52
02:13 ET	1700	42.39
02:15 ET	300	42.34
02:18 ET	200	42.34
02:20 ET	600	42.28
02:22 ET	200	42.27
02:24 ET	300	42.3
02:26 ET	417	42.28
02:27 ET	1200	42.365
02:29 ET	900	42.31
02:31 ET	100	42.305
02:33 ET	100	42.265
02:36 ET	100	42.21
02:38 ET	680	42.26
02:40 ET	200	42.22
02:42 ET	200	42.24
02:44 ET	1400	42.22
02:45 ET	200	42.225
02:47 ET	1536	42.23
02:49 ET	450	42.2
02:51 ET	100	42.275
02:54 ET	800	42.14
02:56 ET	1000	42.15
02:58 ET	100	42.17
03:00 ET	1000	42.21
03:02 ET	305	42.225
03:03 ET	500	42.16
03:05 ET	100	42.145
03:07 ET	1300	42.13
03:09 ET	1100	42.09
03:12 ET	200	42.04
03:14 ET	990	42.08
03:16 ET	3611	41.94
03:18 ET	801	42.035
03:20 ET	3200	41.9867
03:21 ET	2300	41.96
03:23 ET	1793	41.905
03:25 ET	1200	42.06
03:27 ET	500	42.03
03:30 ET	1153	41.91
03:32 ET	1604	41.96
03:34 ET	100	41.9
03:36 ET	1343	41.82
03:38 ET	1100	41.84
03:39 ET	510	41.85
03:41 ET	600	41.81
03:43 ET	2468	41.825
03:45 ET	5559	41.805
03:48 ET	6671	41.76
03:50 ET	6719	41.8
03:52 ET	2200	41.905
03:54 ET	1285	41.86
03:56 ET	3948	41.98
03:57 ET	4274	42.025
03:59 ET	130629	42.12

Data delayed at least 15 minutes.

Apr 11, 2024
- Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Thursday Apr 11, 2024 by Dow Jones
  4:05PM ET on Thursday Apr 11, 2024 by Dow Jones
Mar 28, 2024
- DJ Crinetics Pharmaceuticals Price Target Maintained With a $80.00/Share by JMP Securities, from 10:51AM ET on Thursday Mar 28, 2024 by Dow Jones
  10:51AM ET on Thursday Mar 28, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCRNX Crinetics Pharmaceuticals Inc	3.3B	-11.4x	---
United StatesSWTX SpringWorks Therapeutics Inc	3.3B	-8.9x	---
United StatesIOVA Iovance Biotherapeutics Inc	3.2B	-6.1x	---
United StatesBHVN Biohaven Ltd	3.4B	-6.9x	---
United StatesIBRX Immunitybio Inc	3.4B	-6.5x	---
United StatesVSBC Vitaspring Biomedical Co. Ltd	3.1B	3,311.3x	---
As of 2024-04-26

Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.

Contact Information

Headquarters: 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
Phone: 858-450-6464
Fax: 302-636-5454

Executives

Independent Chairman of the Board: Wendell Wierenga
President, Chief Executive Officer, Co-Founder, Director: R. Scott Struthers
Co-Founder, Chief Scientific Officer: Stephen Betz
Chief Financial Officer: Marc Wilson
Chief Operating Officer: Jeff Knight

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$3.3B
Revenue (TTM)	$4.0M
Shares Outstanding	77.9M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.64
EPS	$-3.70
Book Value	$7.91
P/E Ratio	-11.4x
Price/Sales (TTM)	821.2
Price/Cash Flow (TTM)	---
Operating Margin	-5,547.17%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Crinetics Pharmaceuticals Inc
NASDAQ:CRNXUnited States

Search Criteria

Charts

Recent News

Apr 11, 2024

Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Thursday Apr 11, 2024 by Dow Jones

Mar 28, 2024

DJ Crinetics Pharmaceuticals Price Target Maintained With a $80.00/Share by JMP Securities, from 10:51AM ET on Thursday Mar 28, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar